Lipoxin A4 exerts protective effects against experimental acute liver failure by inhibiting the NF-κB pathway
Authors:
- 5 February 2016
- journal article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 37 (3) , 773-780
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 38 references indexed in Scilit:
- Recent advances in management of acute liver failureIndian Journal of Critical Care Medicine, 2015
- Pro-resolving lipid mediators are leads for resolution physiologyNature, 2014
- Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute InflammationImmunity, 2014
- Spinal Actions of Lipoxin A4 and 17(R)-Resolvin D1 Attenuate Inflammation-Induced Mechanical Hypersensitivity and Spinal TNF ReleasePLOS ONE, 2013
- Lipoxin A4 Increases Survival by Decreasing Systemic Inflammation and Bacterial Load in SepsisShock, 2011
- Lipoxin A 4 and benzo‐lipoxin A 4 attenuate experimental renal fibrosisThe FASEB Journal, 2011
- Novel Anti-Inflammatory-Pro-Resolving Mediators and Their ReceptorsCurrent Topics in Medicinal Chemistry, 2011
- Acute liver failureThe Lancet, 2010
- ATLa, an Aspirin-Triggered Lipoxin A4 Synthetic Analog, Prevents the Inflammatory and Fibrotic Effects of Bleomycin-Induced Pulmonary FibrosisThe Journal of Immunology, 2009
- Posttreatment with Aspirin-Triggered Lipoxin A4 Analog Attenuates Lipopolysaccharide-Induced Acute Lung Injury in Mice: The Role of Heme Oxygenase-1Anesthesia & Analgesia, 2007